Search research articles
Contact Us
Filters
Showing results (191-200 of 214) with videos related to
Page
of 22
Sort By:
Mutation Research
|
July 13, 2001
Host determinants of DNA alkylation and DNA repair activity in human colorectal tissue: O(6)-methylguanine levels are associated with GSTT1 genotype and O(6)-alkylguanine-DNA alkyltransferase activity with CYP2D6 genotype
A C Povey, C N Hall, A F Badawi, et al.
Gene Therapy
|
September 25, 1998
Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase
N Chinnasamy, J A Rafferty, I Hickson, et al.
British Journal of Cancer
|
June 11, 1999
Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines
C J Herring, B Deans, R H Elder, et al.
Experimental Hematology
|
May 30, 2001
O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells
G R Westerhof, J D Down, I Blokland, et al.
British Journal of Cancer
|
May 14, 2008
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
O A Khan, M Ranson, M Michael, et al.
American Journal of Human Genetics
|
September 16, 1999
Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors
J M Varley, G McGown, M Thorncroft, et al.
British Journal of Cancer
|
June 28, 2002
Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours
M J Clemons, M C Bibby, H El Teraifi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1988
Repair of O-alkylpyrimidines in mammalian cells: a present consensus
T P Brent, M E Dolan, H Fraenkel-Conrat, et al.
Gene Therapy
|
September 1, 1999
A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents
J Jelinek, J A Rafferty, R Cmejla, et al.
Gene Therapy
|
March 17, 2006
Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus
A Schambach, B Schiedlmeier, K Kühlcke, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 214) with videos related to
Sort By:
Page
of 22
Mutation Research
|
July 13, 2001
Host determinants of DNA alkylation and DNA repair activity in human colorectal tissue: O(6)-methylguanine levels are associated with GSTT1 genotype and O(6)-alkylguanine-DNA alkyltransferase activity with CYP2D6 genotype
A C Povey, C N Hall, A F Badawi, et al.
Gene Therapy
|
September 25, 1998
Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase
N Chinnasamy, J A Rafferty, I Hickson, et al.
British Journal of Cancer
|
June 11, 1999
Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines
C J Herring, B Deans, R H Elder, et al.
Experimental Hematology
|
May 30, 2001
O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells
G R Westerhof, J D Down, I Blokland, et al.
British Journal of Cancer
|
May 14, 2008
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
O A Khan, M Ranson, M Michael, et al.
American Journal of Human Genetics
|
September 16, 1999
Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors
J M Varley, G McGown, M Thorncroft, et al.
British Journal of Cancer
|
June 28, 2002
Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours
M J Clemons, M C Bibby, H El Teraifi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1988
Repair of O-alkylpyrimidines in mammalian cells: a present consensus
T P Brent, M E Dolan, H Fraenkel-Conrat, et al.
Gene Therapy
|
September 1, 1999
A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents
J Jelinek, J A Rafferty, R Cmejla, et al.
Gene Therapy
|
March 17, 2006
Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus
A Schambach, B Schiedlmeier, K Kühlcke, et al.
Page
of 22